Key Takeaways
- • Private equity firms have invested over $1 trillion in debt-financed healthcare deals over the past decade, yet emerging research demonstrates significant operational and patient safety failures across PE-backed healthcare assets.
- • NYU Stern Center for Business and Human Rights report (March 2026) documents that PE ownership correlates with 25% increases in in-hospital complications, 4.4% reductions in nursing staff, and 11% higher mortality rates in nursing homes, while increasing bankruptcy risk tenfold.
- • High-profile bankruptcies of PE-backed health systems—including Steward Health Care (Cerberus Capital Management, 2024) and Prospect Medical Holdings (Leonard Green & Company, 2025)—have disproportionately harmed low-income and rural communities, triggering state-level regulatory responses.
- • States including Maine and California are implementing stricter oversight mechanisms, including moratoriums on PE hospital acquisitions and corporate practice of medicine (CPOM) statutes that restrict unlicensed entity ownership of medical practices, contrasting sharply with aviation regulatory discipline cited in the headline framework.
- • PE acquisition of physician practices accelerated dramatically—representing 65% of practice acquisitions from 2019–2023, with PE ownership rising to 6.5% by 2024—underscoring sector-wide consolidation trends that lack comparable federal guardrails.
Summary
The private equity sector's penetration of U.S. healthcare has emerged as a significant regulatory flashpoint, with mounting evidence of operational failures and adverse patient outcomes prompting state-level intervention. A March 2026 report from NYU Stern Center for Business and Human Rights synthesized peer-reviewed health outcomes research, bankruptcy records, and transaction data to quantify the sector's impact. The analysis revealed that PE firms have deployed over $1 trillion in debt-financed healthcare transactions over the past decade, yet outcome metrics paint a troubling picture: PE ownership correlates with 25% increases in in-hospital complications, 4.4% reductions in nursing staff, and 11% higher mortality rates in PE-backed nursing homes. The bankruptcy risk multiplier is particularly acute—PE ownership increases bankruptcy likelihood tenfold, with 34 PE-backed healthcare businesses filing for bankruptcy in 2023 alone.
The structural vulnerabilities became evident through high-profile collapses. Steward Health Care, held by Cerberus Capital Management from 2010 to 2021, filed for bankruptcy in 2024, while Prospect Medical Holdings, acquired by Leonard Green & Company over the same period, followed suit in 2025. Both cases demonstrated how the PE operational model—characterized by aggressive leverage deployment, remote financial ownership, and short-term value extraction—proves fundamentally misaligned with healthcare's life-or-death mission requirements. Michael Goldhaber, author of the NYU Stern report, articulated this structural incompatibility: "The private equity model needs to be adapted for the healthcare sector, because otherwise, they're an unhealthy fit. Here, on the one side, you have a business model that is based on public anonymity, legal immunity, remote and financialized ownership and a lack of self-restraining norms. On the other side, you have a sector where all the stakes are life and death."
State regulators have begun imposing discipline absent at the federal level. Maine implemented a one-year moratorium on hospital purchases by PE firms and real estate investment trusts (REITs), signaling political mobilization around healthcare acquisition control. California enacted statutory restrictions rooted in corporate practice of medicine principles, prohibiting unlicensed investors from exerting clinical influence over professional practices. These interventions gain urgency given accelerating PE consolidation in medical practices—65% of physician practice acquisitions from 2019–2023 involved PE acquirers, with PE ownership of practices reaching 6.5% by April 2026. Research literature increasingly documents how PE ownership increases debt burdens, bankruptcy risk, healthcare pricing, and quality deterioration while reducing physician autonomy and patient access, particularly in underserved rural and low-income markets.
The regulatory landscape reflects a bifurcation between federal and state authority following the 2024 election cycle, with states assuming primary responsibility for healthcare transaction oversight while gaps persist in federal guardrails comparable to those governing aviation safety or other heavily regulated sectors. Industry observers note that PE's core leverage and short-horizon models remain fundamentally at odds with healthcare's operational requirements, placing mounting pressure on policymakers to establish binding restrictions on deal structures, leverage deployment, and ownership conduct standards.
The structural vulnerabilities became evident through high-profile collapses. Steward Health Care, held by Cerberus Capital Management from 2010 to 2021, filed for bankruptcy in 2024, while Prospect Medical Holdings, acquired by Leonard Green & Company over the same period, followed suit in 2025. Both cases demonstrated how the PE operational model—characterized by aggressive leverage deployment, remote financial ownership, and short-term value extraction—proves fundamentally misaligned with healthcare's life-or-death mission requirements. Michael Goldhaber, author of the NYU Stern report, articulated this structural incompatibility: "The private equity model needs to be adapted for the healthcare sector, because otherwise, they're an unhealthy fit. Here, on the one side, you have a business model that is based on public anonymity, legal immunity, remote and financialized ownership and a lack of self-restraining norms. On the other side, you have a sector where all the stakes are life and death."
State regulators have begun imposing discipline absent at the federal level. Maine implemented a one-year moratorium on hospital purchases by PE firms and real estate investment trusts (REITs), signaling political mobilization around healthcare acquisition control. California enacted statutory restrictions rooted in corporate practice of medicine principles, prohibiting unlicensed investors from exerting clinical influence over professional practices. These interventions gain urgency given accelerating PE consolidation in medical practices—65% of physician practice acquisitions from 2019–2023 involved PE acquirers, with PE ownership of practices reaching 6.5% by April 2026. Research literature increasingly documents how PE ownership increases debt burdens, bankruptcy risk, healthcare pricing, and quality deterioration while reducing physician autonomy and patient access, particularly in underserved rural and low-income markets.
The regulatory landscape reflects a bifurcation between federal and state authority following the 2024 election cycle, with states assuming primary responsibility for healthcare transaction oversight while gaps persist in federal guardrails comparable to those governing aviation safety or other heavily regulated sectors. Industry observers note that PE's core leverage and short-horizon models remain fundamentally at odds with healthcare's operational requirements, placing mounting pressure on policymakers to establish binding restrictions on deal structures, leverage deployment, and ownership conduct standards.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.